Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
about
Vps33b pathogenic mutations preferentially affect VIPAS39/SPE-39-positive endosomesArthrogryposis-renal dysfunction-cholestasis (ARC) syndrome: from molecular genetics to clinical featuresInvolvement of corneodesmosome degradation and lamellar granule transportation in the desquamation processCurrent Strategies in Diagnosis of Inherited Storage Pool DefectsThe full-of-bacteria gene is required for phagosome maturation during immune defense in Drosophila.Metazoan cell biology of the HOPS tethering complexThe Role of Platelets and ε-Aminocaproic Acid in Arthrogryposis, Renal Dysfunction, and Cholestasis (ARC) Syndrome Associated HemorrhageTwo novel VPS33B mutations in a patient with arthrogryposis, renal dysfunction and cholestasis syndrome in mainland China.ARC syndrome with high GGT cholestasis caused by VPS33B mutations.Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.Inherited secondary nephrogenic diabetes insipidus: concentrating on humans.Glomerular involvement in the arthrogryposis, renal dysfunction and cholestasis syndrome.Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes.ARC Syndrome-Linked Vps33B Protein Is Required for Inflammatory Endosomal Maturation and Signal Termination.Identification of novel mutations in the VPS33B gene involved in arthrogryposis, renal dysfunction, and cholestasis syndrome.Aberrant splicing by a mutation, c.403+2T>A, in Korean patients with arthrogryposis-renal-dysfunction-cholestasis syndrome.
P2860
Q24315069-D74C2E26-A061-4DD8-B0E9-FCE41A191340Q27011405-0DB655C4-3B61-484D-A542-97260C69124EQ29305190-F5C0A995-9810-4FAB-8BA9-52B7E1883FF1Q33393005-A2658CFE-5199-4E27-8F7C-2651550CCFD8Q35003581-B1A87F8F-8493-4F6C-9B7D-AF22DA065D0EQ35214573-14D95212-3145-455D-AD8B-3FA45E6182F7Q36494244-C21A27D5-6C4F-46B3-A508-6198D86A9CEEQ37454550-074D638F-ACF9-4116-B822-A1CB40D580EAQ37724726-36FEA4EA-C7FF-4803-AEC4-91507BD9F2C7Q37980726-D92F131F-6458-4DFE-A962-847150369592Q38077934-3715A3EF-DFFF-4F11-9104-8808AC9419A9Q38505463-27FA3336-17E6-4A3B-B2E4-21536A378DF4Q39672346-7C76820D-606F-4C4E-B279-393714A369EDQ41699575-E471E9BB-6FD9-4279-BFB4-F8D76DCC4145Q53275909-2E7EDF57-2BB5-4782-8BFB-CE192AB92B50Q53410247-667B1F50-457E-43BE-8D9B-88ED14EE1AC7
P2860
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@en
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@nl
type
label
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@en
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@nl
prefLabel
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@en
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@nl
P2093
P1476
Clinical characteristics and VPS33B mutations in patients with ARC syndrome.
@en
P2093
Gu-Hwan Kim
Han-Wook Yoo
Jin-Joo Lee
Joo Young Jang
Kyung Mo Kim
Young Seo Park
P304
P356
10.1097/MPG.0B013E31817FCB3F
P407
P577
2009-03-01T00:00:00Z